News

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis

Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of its MyoPro line of powered orthoses after raising growth capital through its IPO in June 2017. Read more >>
Read more...

Women-led U.S. startups attract just fraction of venture money

In the new study, researchers examined nearly 7,000 U.S. companies that received venture capital between 2011 and 2013. They then identified companies with women on their executive team. Just why women-led companies were recipient of less venture capital raised questions about the industry's inner workings, said co-author Candida Brush, a professor of entrepreneurship at Babson College in Massachusetts. Read more >>
Read more...

Babson College to Expand to Miami

Massachusetts-based Babson College, the recognized world leader in entrepre­neurship education, is expanding to Miami, Florida, with three graduate programs—including the Blended Learning MBA, ranked No. 1 for alumni earnings and top 10 worldwide by Financial Times (FT), The Princeton Review, and Entrepreneur magazine. Read more >>
Read more...

Blind Rock Hill mother sees family again with pair of high-tech glasses

Three years ago, Rock Hill mother Brandi Jones Ervin was robbed of her eyesight. After she had gastric bypass surgery, she noticed a blur that could not be rubbed away. She couldn’t cook, she couldn’t drive, and she couldn’t watch her daughter perform in the high school marching band. We, at FOX46 Charlotte, worked to get results for Ervin by way of high-tech Esight glasses. Read more >>
Read more...

Chronix Biomedical $8.00 million Fundraising. John DiPietro Filed Jul 18 SEC Filing

Chronix Biomedical Inc, Corporation just had published form D about $8.00 million equity financing. This is a new filing. Chronix Biomedical was able to sell $3.31 million so far. That is 41.34 % of the fundraising. The total financing amount was $8.00 million. This form was filed on 2017-07-18. The reason for the financing was: unspecified. The fundraising still has about $4.69 million more and is not closed yet. We have to wait more to see if the offering will...
Read more...

Drug for concussion, stroke found by UT scientist moves closer to human trials

Astrocyte Pharmaceuticals, the company Lechleiter founded with William Korinek of Boston, completed Monday its first round of financing that raised roughly $2.4 million in fresh capital. The fledgling company had $670,000 in seed funding from the federal government since 2014. Lechleiter hopes the drug, which is at least 7 years away from market, could be easily administered by any football coach or paramedic to mitigate the effects of concussions or strokes. Read more >>
Read more...